A Phase 1, multicenter, open-label, dose-escalation study of SNF-2FF in patients with advanced solid tumors
Clinical Trial Grant
Awarded By
Seattle Genetics, Inc
Start Date
September 28, 2017
End Date
January 22, 2020
Awarded By
Seattle Genetics, Inc
Start Date
September 28, 2017
End Date
January 22, 2020